San Diego Compounding Phrmcy is categorized under in San Diego, CA and active since 2005.
San Diego Compounding Phrmcy was established in 2005, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Jerome Greene, Owner at the company’s single location by writing to 5395 Ruffin Road # 104, San Diego, California CA 92123 or by phoning (858) 277-8884. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | San Diego Compounding Phrmcy |
| Contact Person: | Jerome Greene, Owner |
| Address: | 5395 Ruffin Road # 104, San Diego, California 92123 |
| Phone Number: | (858) 277-8884 |
| Website Address: | sandiegocompoundingpharmacy.com |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2005 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
San Diego Compounding Phrmcy was started in 2005 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Jerome Greene, Owner for inquiries that concern San Diego Compounding Phrmcy by calling the company number (858) 277-8884, as your correspondence is most welcome. Additionally, the physical location of the single location of San Diego Compounding Phrmcy can be found at the coordinates 32.83241,-117.12661 as well as the street address 5395 Ruffin Road # 104 in San Diego, California 92123.
For its online presence, you may visit San Diego Compounding Phrmcy’s website at sandiegocompoundingpharmacy.com and engage with its social media outlets through on Twitter and on Facebook.